Jefferies Group now has a $88.00 target price on the stock. The Hedge Fund company now holds 126,819 shares of ESRX which is valued at $9,686,435. STEVENS MARK A is one of the largest insider shareholders in Express Scripts Holding Company (NASDAQ:ESRX), according to U.S. Securities and Exchange Commission (SEC) filings. The stock’s Dividend stands at 0 and Dividend Yield stands at 0 Percent. Meanwhile for the quarter, the brokerages targeted EPS of $1.57.
Advertisement
The Relative Volume of the company is 2.09 and Average Volume (3 months) is 3.5 million.
Express Scripts Holding Company (NASDAQ:ESRX) stock is now trading at about $72.31 and lots of rating firms seem to have a target price set on the stock.
Insiders own 5% percent of the stock. Quadrant Capital Group LLC boosted its position in Express Scripts Holding by 2.2% in the second quarter. Following the transaction, the EVP, Operations is left with a stake of 352,188 shares, now valued at $25466714. Express Scripts Holding Company makes up approx 0.12% of First Trust Advisors Lp’s portfolio. Now the company has earned “Buy” from 3 equity analysts. Zacks Investment Research lowered shares of Express Scripts Holding from a buy rating to a hold rating in a research report on Thursday, August 4th.
Express Scripts Holding Company (NASDAQ:ESRX) remained bullish with an increase +0.31% putting the price on the $73.35 per share in last trading session ended on 8/30/2016. Pending market entry later this year for the country’s first follow-on insulin, Basaglar (insulin glargine), Express Scripts plans to add Basaglar as a preferred product for the National Preferred Formulary, alongside the originator product Lantus (insulin glargine).
Some buy side analysts are also providing their Analysis on Express Scripts Holding Company, where 3 analysts have rated the stock as Strong buy, 6 analysts have given a Buy signal, 12 said it’s a HOLD, 2 reported it as Underperform and 1 analysts rated the stock as Sell. Analyst had a consensus estimate of $1.57. The company presently has an average rating of Hold and an average target price of $81.26.
Analysts’ mean recommendation for Express Scripts Holding Company’s (ESRX) stands at 2.70. The company has a 20-day simple moving average of -4.11% and a volume of -4.11%. This appreciation has taken its market cap to $46.08B and a price-to-earnings ratio to 18.07. The Company Touched its 52-Week High on Nov 6, 2015 and 52-Week Low on Feb 11, 2016.
MER Telemanagement Solutions Ltd. (NASDAQ:MTSL) announced its financial results for the second quarter of 2016.
EPS growth in next year is estimated to reach 7.62% while EPS growth estimate for this year is set at 34.70%. The company had revenue of $25222.00 million for the quarter, compared to analysts expectations of $25392.31 million. The business’s revenue was down.9% compared to the same quarter a year ago. This represented an Earnings Surprise of 0%.
Advertisement
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
